STAT+: ASCO day 2: A tragic paradox, Gilead updates, and lots of Pfizer news
This is the web version of STAT’s special newsletter from the annual meeting of the American Society of Oncology. For more updates on the latest in cancer news, sign up for our Cancer Briefing newsletter here.
ASCO is usually sweltering, but it’s surprisingly chilly today. We’re back with a roundup of tragic paradoxes, a race for new breast cancer drugs, and all that jazz.
First, though, we want to thank everyone who turned out for our STAT@ASCO event last night. It was a packed house, and a great crowd. A reminder: Our virtual STAT Recap event about the conference will be Wednesday, and it is not too late to sign up.
Matthew Herper, Adam Feuerstein, and Angus Chen
Go to statnews